RL's double-digit online sales growth highlights its digital-first strategy as it works to counter softer retail trends worldwide.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Novo To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Novo between May 7, 2025, to July 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 15, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Novo Nordisk A/S ("Novo" or the …

AMZN pushes same-day grocery to 2,300 cities by year-end, blending fresh produce with Prime delivery as Walmart, Target, Kroger race to defend market share.

UnitedHealth Group (UNH) shares surged Friday after Warren Buffett's Berkshire Hathaway (BRK.A, BRK.B) revealed a stake in the embattled healthcare giant.

U.S. equities were mixed at midday as a report on retail sales showed consumers are continuing to spend. The Dow Jones Industrial Average was up slightly, while the S&P 500 and Nasdaq fell.

Every month I share what closed-end funds I've been buying in the last month. For July, that included swapping out some holdings in favor of others and consolidating my portfolio a bit. In doing that, it also included swapping out of two CEFs in favor of ETF positions, one of which I already held a position in.

PHILADELPHIA , Aug. 15, 2025 /PRNewswire/ -- Berger Montague PC is investigating potential securities fraud claims on behalf of investors of Altimmune, Inc. (NASDAQ: ALT) ("Altimmune" or the "Company") following the filing of a securities class action lawsuit filed on behalf of investors who purchased or otherwise acquired Altimmune securities between August 10, 2023 through June 25, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Altimmune securities during the Class Period may, no later than October 6, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Federal support could get the troubled chip maker over some hurdles, but risks great harm to the U.S. tech sector.

The advanced battery firm recently posted second-quarter 2025 results that showcased a dramatic surge in revenue and, more critically, a landmark achievement in profitability.

@Stockstotrade's Tim Bohen talks about Opendoor's (OPEN) "fundamental case" for real estate, even after shares exploded to the upside in an ongoing meme stock craze. He sees something similar in Rigel Pharmaceuticals (RIGL), noting the stock nearly doubling just in August.

SDRL secures new Gulf of America contracts for West Vela and Sevan Louisiana, boosting its $2.5B order backlog.

CL's innovation push spans premium oral, personal, home and pet care to drive market share growth in 2025 despite headwinds.

AFG stock gains from new business opportunities, increased exposures, a better renewal rate environment, and effective capital deployment.

Subscribers to Schaeffer's Weekend Trader options recommendation service received this SN commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters.

ATLANTA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Gray Media has promoted Bob Kroeger Chief Technology Officer for the company, effective immediately. Bob has served as Chief Information Officer for both Gray and Raycom Media. He succeeds David Burke, who retired on July 31 and will continue advising Gray through the end of the year.

Shamis Gentile notifies investors a securities fraud class action has been filed on behalf of securities and options investors in Charter Communications.

Berkshire Hathaway Inc. quietly built a massive stake in UnitedHealth Group, and I really like this. From oil and steel to homebuilders and healthcare, Berkshire is positioning for recession and stagflation resilience. After a 10% BRK dip post Buffett retirement, bullish momentum signals a potential rally ahead.

Can Target turn it around?

The company's key customers include Intel and Taiwan Semiconductor Manufacturing.

Cosan S.A. (NYSE:CSAN ) Q2 2025 Earnings Conference Call August 15, 2025 9:00 AM ET Company Participants Marcelo Eduardo Martins - CEO & Vice Chairman Rodrigo Araujo Alves - Chief Financial & Investor Relations Officer Conference Call Participants Gabriel Coelho Barra - Citigroup Inc., Research Division Gustavo Sadka - Banco Bradesco BBI S.A., Research Division Matheus Enfeldt - UBS Investment Bank, Research Division Monique Martins Greco Natal - Itaú Corretora de Valores S.A.